Literature DB >> 15086398

Genetic variants in the CCR gene cluster and spontaneous viral elimination in hepatitis C-infected patients.

S Mascheretti1, H Hinrichsen, S Ross, P Buggisch, J Hampe, U R Foelsch, S Schreiber.   

Abstract

Hepatitis C virus (HCV) infection results in chronic hepatitis in more than 80% of infected patients while 10-20% of patients recover spontaneously. Host genetic factors may influence the ability to clear the virus after infection. Six single nucleotide polymorphisms and a 32 bp deletion in the genes coding for CCR3, CCR2 and CCR5 (which are all located in a cluster on chromosome 3) were investigated in 465 consecutively recruited patients infected with HCV and 370 matched controls. Genetic variants were tested for association with spontaneous viral elimination and, in the chronically infected patients, stage of fibrosis and response to antiviral therapy. The G190A polymorphism (variant allele Ile64) in the first transmembrane domain of CCR2 was under-represented in the 29 patients who had cleared the hepatitis C virus spontaneously (P = 0.018). None of the other variants in the CCR gene cluster showed association with the natural course of the infection, stage of fibrosis or response to therapy.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15086398      PMCID: PMC1809016          DOI: 10.1111/j.1365-2249.2004.02444.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  52 in total

1.  An integrated system for high throughput TaqMan based SNP genotyping.

Authors:  J Hampe; A Wollstein; T Lu; H J Frevel; M Will; C Manaster; S Schreiber
Journal:  Bioinformatics       Date:  2001-07       Impact factor: 6.937

2.  Study of host- and virus-related factors associated with spontaneous hepatitis C virus clearance.

Authors:  L Alric; M Fort; J Izopet; J P Vinel; C Bureau; K Sandre; J P Charlet; M Beraud; M Abbal; M Duffaut
Journal:  Tissue Antigens       Date:  2000-08

3.  Viral clearance in hepatitis C (1b) infection: relationship with human leukocyte antigen class II in a homogeneous population.

Authors:  L J Fanning; J Levis; E Kenny-Walsh; F Wynne; M Whelton; F Shanahan
Journal:  Hepatology       Date:  2000-06       Impact factor: 17.425

4.  Interleukin 10 polymorphisms as predictors of sustained response in antiviral therapy for chronic hepatitis C infection.

Authors:  L J Yee; J Tang; A W Gibson; R Kimberly; D J Van Leeuwen; R A Kaslow
Journal:  Hepatology       Date:  2001-03       Impact factor: 17.425

5.  Genetic polymorphisms of CC chemokine receptor 3 in Japanese and British asthmatics.

Authors:  K Fukunaga; K Asano; X Q Mao; P S Gao; M H Roberts; T Oguma; T Shiomi; M Kanazawa; C N Adra; T Shirakawa; J M Hopkin; K Yamaguchi
Journal:  Eur Respir J       Date:  2001-01       Impact factor: 16.671

6.  Tumor necrosis factor gene polymorphisms in patients with cirrhosis from chronic hepatitis C virus infection.

Authors:  L J Yee; J Tang; J Herrera; R A Kaslow; D J van Leeuwen
Journal:  Genes Immun       Date:  2000-08       Impact factor: 2.676

7.  HLA class II genes determine the natural variance of hepatitis C viral load.

Authors:  L J Fanning; J Levis; E Kenny-Walsh; M Whelton; K O'Sullivan; F Shanahan
Journal:  Hepatology       Date:  2001-01       Impact factor: 17.425

8.  Influence of MHC class II genotype on outcome of infection with hepatitis C virus. The HENCORE group. Hepatitis C European Network for Cooperative Research.

Authors:  M Thursz; R Yallop; R Goldin; C Trepo; H C Thomas
Journal:  Lancet       Date:  1999 Dec 18-25       Impact factor: 79.321

9.  Influence of HLA haplotypes on the clinical courses of individuals infected with hepatitis C virus.

Authors:  N Kuzushita; N Hayashi; T Moribe; K Katayama; T Kanto; S Nakatani; T Kaneshige; T Tatsumi; A Ito; K Mochizuki; Y Sasaki; A Kasahara; M Hori
Journal:  Hepatology       Date:  1998-01       Impact factor: 17.425

10.  The outcome of acute hepatitis C predicted by the evolution of the viral quasispecies.

Authors:  P Farci; A Shimoda; A Coiana; G Diaz; G Peddis; J C Melpolder; A Strazzera; D Y Chien; S J Munoz; A Balestrieri; R H Purcell; H J Alter
Journal:  Science       Date:  2000-04-14       Impact factor: 47.728

View more
  9 in total

1.  CCR5Delta32 mutation does not influence the susceptibility to HCV infection, severity of liver disease and response to therapy in patients with chronic hepatitis C.

Authors:  Ankur Goyal; P V Suneetha; G T Kumar; Deepak K Shukla; Naveen Arora; Shiv K Sarin
Journal:  World J Gastroenterol       Date:  2006-08-07       Impact factor: 5.742

2.  CCL2-2518 A/G and CCR2 190 A/G do not influence the outcome of hepatitis C virus infection in the Spanish population.

Authors:  M-A Montes-Cano; J-R Garcia-Lozano; J Aguilar-Reina; M Romero-Gomez; N Barroso; A Nunez-Roldan; M-F Gonzalez-Escribano
Journal:  World J Gastroenterol       Date:  2007-04-21       Impact factor: 5.742

3.  Association between low molecular polypeptide 7 single nucleotide polymorphism and response to therapy in hepatitis C virus infection.

Authors:  Moataza H Omran; Basma E Fotouh; Samar S Youssef; Noha E Ibrahim; Wael Nabil; El-Sayed M Mahdy; Wafaa G Shosha; Mostafa K El-Awady
Journal:  World J Hepatol       Date:  2013-03-27

Review 4.  Recognition of genetic factors influencing the progression of hepatitis C : potential for personalized therapy.

Authors:  Julie R Jonsson; David M Purdie; Andrew D Clouston; Elizabeth E Powell
Journal:  Mol Diagn Ther       Date:  2008       Impact factor: 4.074

5.  Role of host genetic factors in the outcome of hepatitis C virus infection.

Authors:  Bertram Bengsch; Robert Thimme; Hubert E Blum
Journal:  Viruses       Date:  2009-08-05       Impact factor: 5.818

Review 6.  Regulation and functional roles of chemokines in liver diseases.

Authors:  Sheng Cao; Mengfei Liu; Tejasav S Sehrawat; Vijay H Shah
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2021-05-11       Impact factor: 73.082

7.  Effects of the Chemokine Receptor 5 (CCR5)-Delta32 Mutation on Hepatitis C Virus-Specific Immune Responses and Liver Tissue Pathology in HCV Infected Patients.

Authors:  Abdulkerim Yilmaz; Hakan Alagozlu; Ozturk Ozdemir; Sema Arici
Journal:  Hepat Mon       Date:  2014-07-01       Impact factor: 0.660

Review 8.  Beyond HIV infection: Neglected and varied impacts of CCR5 and CCR5Δ32 on viral diseases.

Authors:  Joel Henrique Ellwanger; Bruna Kulmann-Leal; Valéria de Lima Kaminski; Andressa Gonçalves Rodrigues; Marcelo Alves de Souza Bragatte; José Artur Bogo Chies
Journal:  Virus Res       Date:  2020-05-30       Impact factor: 3.303

9.  The Role of Genetic Factors in the Development of Acute Respiratory Viral Infection COVID-19: Predicting Severe Course and Outcomes.

Authors:  Mikhail M Minashkin; Nataliya Y Grigortsevich; Anna S Kamaeva; Valeriya V Barzanova; Alexey A Traspov; Mikhail A Godkov; Farkhad A Ageev; Sergey S Petrikov; Nataliya V Pozdnyakova
Journal:  Biomedicines       Date:  2022-02-25
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.